Board of Directors

  • Alan Faichney

    Alan Faichney


    Alan has 35 years of commercial and company leadership experience, building international businesses in the technology sector.  Beginning his career in the aerospace industry, Alan later joined the oil exploration industry where he held key technical and strategic roles in product and market development.  Alan brings great experience in strategic analysis and international business planning, detailed and effective operational abilities, negotiation skills, corporate finance and investment.

  • Iain McWilliam

    Iain McWilliam

    Chief Executive Officer

    Iain has been CEO of Arrayjet since 2010 and led the introduction of services which have reshaped the company.  Iain joined Arrayjet in 2007 and held positions of Chief Operating Officer, Chief Science Officer and Senior Scientist.  He has a molecular biology background and was previously a Research Fellow with Cancer Research UK (Dundee), holds PhD and Masters degrees from St Andrews University and an Honours degree from Edinburgh University.

  • Kirsty Macfarlane

    Kirsty Macfarlane

    Chief Operating Officer

    Kirsty joined Arrayjet in November 2011 and as Chief Operating Officer she coordinates operations across the company. With over 15 years experience in Operations Management within the contract research (CRO) industry, Kirsty has worked at both Quintiles and Aptuit within the preclinical drug development field.  During this time she helped establish and expand in vitro cardiovascular and ion channel services and latterly became Director of Pharmacology.  Kirsty holds a PhD in pharmacology and a degree in physiology from the University of Glasgow.

  • Martin Ramsay

    Martin Ramsay

    Finance Director

    Martin Ramsay joined Arrayjet in January 2013 in order to bring a deeper insight to the company finances.  Appointed to the board in 2014, Martin brings his experience from Mpathy Medical, Lab901, Vitrology and ScoLocate.  Martin also represents Archangel Informal Investments Ltd on the board as their investor’s director.